iGMDRD574
Canonical SMILES: C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI: InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1
InChI Key: HFNKQEVNSGCOJV-OAHLLOKOSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
|---|---|---|---|---|---|
Standard NameRuxolitinib CHEMBLCHEMBL1795071 CHEMBL1789941 Pubchem CID25126800 DRUGBANK IDDB08877 Drug StatusAlone Drug TypeSmall Molecule | |||||
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzolesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsJanus Kinases, antagonists & inhibitorsKinase InhibitorMyelosuppressive AgentsProtein Kinase InhibitorsDrug Pathways:
Other, kinasesDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot
Models in Ruxolitinib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
|---|---|---|---|---|---|---|---|---|
| No matching records found | ||||||||
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.